Literature DB >> 1330579

Evidence for a role of CD28RE as a response element for distinct mitogenic T cell activation signals.

A Civil1, M Geerts, L A Aarden, C L Verweij.   

Abstract

T lymphocytes can be induced to produce interleukin (IL)-2 and proliferate upon T cell receptor (TcR) occupancy together with a CD28-induced co-stimulatory signal. The T cell surface molecule CD28 is believed to function as a regulator in T cell activation at both the level of lymphokine mRNA stabilization and gene transcription. Activation of IL-2 gene transcription via CD28 has been shown to be mediated through a kappa B-like sequence, called CD28RE. DNA binding analysis revealed that the CD28-induced signal is involved in the induction of CD28RE binding activity. Here, we demonstrate that the induction of CD28RE binding activity is not specific for the CD28-induced signal. Our data indicate that distinct mitogenic T cell activation signals converge on the induction of CD28RE binding activity, and suggest a crucial role for this activity in the IL-2 enhancer responsiveness to different modes of T cell activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330579     DOI: 10.1002/eji.1830221142

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding.

Authors:  E Parra; M Varga; G Hedlund; T Kalland; M Dohlsten
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

2.  Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus.

Authors:  J H Yeh; P Lecine; J A Nunes; S Spicuglia; P Ferrier; D Olive; J Imbert
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites.

Authors:  V S Shapiro; K E Truitt; J B Imboden; A Weiss
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

4.  Requirements for interleukin 2 promoter transactivation by the Tax protein of human T-cell leukemia virus type 1.

Authors:  V E Curtiss; R Smilde; K L McGuire
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells.

Authors:  R G Bryan; Y Li; J H Lai; M Van; N R Rice; R R Rich; T H Tan
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  Regulation of interleukin 2 gene expression by CD28 costimulation in mouse T-cell clones: both nuclear and cytoplasmic RNAs are regulated with complex kinetics.

Authors:  S W Umlauf; B Beverly; O Lantz; R H Schwartz
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

7.  RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.

Authors:  J H Lai; G Horvath; J Subleski; J Bruder; P Ghosh; T H Tan
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

8.  AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes.

Authors:  M Rincón; R A Flavell
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

9.  Apoptosis signaling is altered in CD4⁺CD25⁺FoxP3⁺ T regulatory lymphocytes in pre-eclampsia.

Authors:  Dorota Darmochwal-Kolarz; Shigeru Saito; Jacek Tabarkiewicz; Bogdan Kolarz; Jacek Rolinski; Bozena Leszczynska-Gorzelak; Jan Oleszczuk
Journal:  Int J Mol Sci       Date:  2012-05-29       Impact factor: 6.208

10.  Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways.

Authors:  D R DeSilva; W S Feeser; E J Tancula; P A Scherle
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.